Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom

Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom

US Patent 10006050 · Granted Jun 26, 2018

Estimated economic value: $98,548,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Liquid applicator for delivering vaccines2025
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Modified Marek's disease virus, and vaccines made therefrom2025
Liquid applicator for delivering vaccines2023
Modified Marek's disease virus, and vaccines made therefrom2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2022
Liquid applicator for delivering vaccines2021
Recombinant vectors expressing antigens of avian influenza virus and uses thereo2021
Recombinant viral vector systems expressing exogenous feline paramyxovirus genes2021
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2020
Liquid applicator for delivering vaccines2020
PRRSV minor protein-containing recombinant viral vectors and methods of making a2020